Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

NCT07413809 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

92

Enrollment

OTHER_GOV

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Fosaprepitant
DRUG: Fosaprepitant
DRUG: Tropisetron
DRUG: Olanzapine
DRUG: Dexamethasone

Sponsor

The Affiliated People's Hospital of Ningbo University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]